Southwest Oncology Group 0408

LAUR Repository

Show simple item record

dc.contributor.author Abdalla, Eddie
dc.contributor.author Eng, Cathy
dc.contributor.author Madary, Alice
dc.contributor.author Vauthey, Nicolas
dc.date.accessioned 2015-11-12T07:52:25Z
dc.date.available 2015-11-12T07:52:25Z
dc.date.issued 2015-11-12
dc.identifier.issn 1533-0028 en_US
dc.identifier.uri http://hdl.handle.net/10725/2540
dc.language.iso en en_US
dc.title Southwest Oncology Group 0408 en_US
dc.type Article en_US
dc.description.version Published en_US
dc.title.subtitle Phase II Trial of Neoadjuvant Capecitabine/Oxaliplatin/Bevacizumab for Resectable Colorectal Metastases in the Liver en_US
dc.author.school SOM en_US
dc.author.idnumber 201100945 en_US
dc.author.woa N/A en_US
dc.author.department N/A en_US
dc.description.embargo N/A en_US
dc.relation.journal Clinical Colorectal Cancer en_US
dc.journal.volume 5 en_US
dc.journal.issue 6 en_US
dc.article.pages 436-438 en_US
dc.keywords 5-Fluorouracil en_US
dc.keywords Leucovorin en_US
dc.keywords R0 resection en_US
dc.identifier.doi http://dx.doi.org/10.3816/CCC.2006.n.015 en_US
dc.identifier.ctation Abdalla, E. K., Eng, C., Madary, A., & Vauthey, J. N. (2006). Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clinical colorectal cancer, 5(6), 436-438. en_US
dc.author.email eddie.abdalla@lau.edu.lb

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR

Advanced Search


My Account